Real-World Study of Everolimus in Advanced Progressive Neuroendocrine Tumors

Everolimus is a valid therapeutic option for neuroendocrine tumors (NETs); however, data in a real-world setting outside regulatory trials are sparse. The aim of this study was to determine everolimus tolerability and efficacy, in relation to previous treatments, in a compassionate use program. A to...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Panzuto, Francesco, Rinzivillo, Maria, Fazio, Nicola, de Braud, Filippo, Luppi, Gabriele, Zatelli, Maria Chiara, Lugli, Francesca, Tomassetti, Paola, Riccardi, Ferdinando, Nuzzo, Carmen, Brizzi, Maria Pia, Faggiano, Antongiulio, Zaniboni, Alberto, Nobili, Elisabetta, Pastorelli, Davide, Cascinu, Stefano, Merlano, Marco, Chiara, Silvana, Antonuzzo, Lorenzo, Funaioli, Chiara, Spada, Francesca, Pusceddu, Sara, Fontana, Annalisa, Ambrosio, Maria Rosaria, Cassano, Alessandra, Campana, Davide, Cartenì, Giacomo, Appetecchia, Marialuisa, Berruti, Alfredo, Colao, Annamaria, Falconi, Massimo, Delle Fave, Gianfranco
Format: Artigo
Idioma:Inglês
Publicat: AlphaMed Press 2014
Matèries:
Gastrointestinal Cancer
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4153458/
https://ncbi.nlm.nih.gov/pubmed/25117065
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2014-0037
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars